EFFICACY AND SAFETY OF SETMELANOTIDE IN PATIENTS AGED 2 TO <6 YEARS WITH RARE MELANOCORTIN-4 RECEPTOR PATHWAY DISEASES OF OBESITY: INTERIM RESULTS FROM VENTURE, A PHASE 3, MULTICENTER, 1-YEAR, OPEN-LABEL TRIAL
HORMONE RESEARCH IN PAEDIATRICS（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined